KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Rheumatology(.)Archives of Rheumatology / 2012 / Cilt: 27 - Sayı: 3

Behçet Hastalığı ile Ankilozan Spondilit Birlikteliğinde Anti-TNF-Alfa Tedavisi

Anti-TNF-Alpha Therapy for Concomitant Behçet's Disease and Ankylosing Spondylitis

Ali Erdem BAKİ
Hakan TURAN
Esra ÇELEBİ
Mustafa ÖZŞAHİN
Safinaz ATAOĞLU
Sayfa
214–216
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

BAKİ, A. E., TURAN, H., ÇELEBİ, E., ÖZŞAHİN, M., ATAOĞLU, S. (2022). Behçet Hastalığı ile Ankilozan Spondilit Birlikteliğinde Anti-TNF-Alfa Tedavisi. Turkish Journal of Rheumatology(.)Archives of Rheumatology, Cilt: 27 - Sayı: 3, 214–216. https://ajindex.com/articles/614182

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

  1. Çelik C, Uçan H, Uçkun AC, Alemdaroğlu E. Coexistence of Behçet's disease and ankylosing spondylitis. Turk J Rheumatol 2011;26:271-2. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990;335:1078-80.
  2. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
  3. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 2005;25:280-4.
  4. Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003;62:817-24.
  5. Borman P, Bodur H, Ak G, Bostan EE, Barça N. The coexistence of Behçet's disease and ankylosing spondylitis. Rheumatol Int 2000;19:195-8. Turk J Rheumatol 216 van Laar JA, Missotten T, van Daele PL, Jamnitski A, Baarsma GS, van Hagen PM. Adalimumab: a new modality for Behçet's disease? Ann Rheum Dis 2007;66:565-6.
  6. Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, et al. Anti-TNF therapy in the management of Behcet's disease-review and basis for recommendations. Rheumatology (Oxford) 2007;46:736-41.
  7. Lindstedt EW, Baarsma GS, Kuijpers RW, van Hagen PM. Anti-TNF-alpha therapy for sight threatening uveitis. Br J Ophthalmol 2005;89:533-6.
  8. Yildiz N, Alkan H, Ardic F, Topuz O. Successful treatment with adalimumab in a patient with coexisting Behçet's disease and ankylosing spondylitis. Rheumatol Int 2010;30:1511-4.